RightAnswer Knowledge Solutions Search Results for Febuxostat

New Search  |  Search Results (Febuxostat)  |  Index of Example Chemical Results Pages
register now
RightAnswer Knowledge Solutions provides access to hundreds of data sources. Our premier and proprietary sources include fully-researched documents from well-established experts in the chemical and HazMat fields.

A search in our system for this chemical would return results – all in one place -- in the following categories from the listed data sources.
  • Chemical Identification
  • Environmental Hazards
  • First Aid/Medical Treatment
  • Handling/Storage/Shipping/Waste Management
  • Personal Protection
  • Physical Hazards/Corrective Response Actions
  • Physical/Chemical Properties
  • Regulatory/Standards/Labels
  • Report Abstracts and Studies
  • Reproductive Risk
  • Toxicology/Health Hazards/Exposure
Example of Acute Exposure data from MEDITEXT.

RightAnswer Proprietary Data Sources:

HAZARDTEXT™ Documentshelp
MEDITEXT® Documentshelp

All Other Data Sources:

LOLI® Listingshelp
REPROTOX® Documentshelp
RTECS® Registryhelp
TERIS Documentshelp

ChemID External Links:

Other Government Links Searched via RegsKnowledge:

State Environmental Regulationshelp
CFR Regulationshelp

Example Content from MEDITEXT for Febuxostat:

Please note: this is an extract of information from a larger document. Full document and details are available by subscription.


  1. USES: Non-purine selective xanthine oxidase inhibitor used for chronic management of hyperuricemia in patients with gout.
  1. PHARMACOLOGY: Decreases serum uric acid.
  1. EPIDEMIOLOGY: At the time of this review, there were no reports of human overdose.
    1. COMMON: Liver enzyme elevations, headaches, flushing, dizziness, nausea, arthralgia, and rash. An increase in gout flares has been reported following initiation of febuxostat therapy.
    1. TOXICITY: At the time of this review, there was no overdose information available. Overdose effects are anticipated to be an extension of adverse effects observed following therapeutic doses.
© 2011-2021 RightAnswer.com, Inc. and/or its licensors. All rights reserved. No claim to original U.S. Govt. works.